MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2024 * | 78.66M 84.58M | Sales 2025 * | 89.78M 96.53M | Capitalization | 72.71M 78.18M |
---|---|---|---|---|---|
Net income 2024 * | -26M -27.95M | Net income 2025 * | -17M -18.28M | EV / Sales 2024 * | 2.24 x |
Net Debt 2024 * | 103M 111M | Net Debt 2025 * | 121M 130M | EV / Sales 2025 * | 2.16 x |
P/E ratio 2024 * |
-2.86
x | P/E ratio 2025 * |
-4.24
x | Employees | 300 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.92% |
Latest transcript on MDxHealth SA
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 19-02-17 | |
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 19-07-21 |
Miriam Reyes
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 74 | 21-09-28 |
Eric Bednarski
BRD | Director/Board Member | 52 | 20-07-29 |
Hilde Windels
BRD | Director/Board Member | 59 | 17-10-31 |
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+40.71% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |